Document is current

Article History

Received: 17 October 2024

Accepted: 11 June 2025

First Online: 1 July 2025

Change Date: 7 August 2025

Change Type: Update

Change Details: The original online version of this Article was revised: The original version of this Article contained errors in the Reference list, where References 19 and 54 were incorrect. 19. Yongjun et al. Discordant memory B cell and Circulating anti-Env antibody responses in HIV-1 infection. <i>Proc. Natl. Acad. Sci. U S A.</i> <b>106</b> (10), 3952–3957 (2009). 54. Yu, L. et al. Potent and broadly neutralizing antibodies against sarbecoviruses. They now read: 19. Guan, Y. et al. Discordant memory B cell and Circulating anti-Env antibody responses in HIV-1 infection. Proc. Natl. Acad. Sci. U S A. 106 (10), 3952–3957 (2009). 54. Yu L, et al. Potent and broadly neutralizing antibodies against sarbecoviruses elicited by single ancestral SARS-CoV-2 infection. Commun Biol. 6(8), 378 (2025). The original Article has been corrected.

Declarations

:

: The authors declare no competing interests.

: L.Y. and Y.G. have filed patent applications for 825, 843, 826, and 846 antibodies against SARS-CoV-2 (PCT/CN2021/135785 and 202180104547.4).

: This study was approved by the Human Ethics Committee of Guangzhou Eighth People’s Hospital (202020153) and was conducted in accordance with Chinese rules and regulations for the protection of human subjects. All subjects provided written informed consent for the research use of their blood samples. Animal study was approved by the Experimental Animal Ethics Committee of the First Affiliated Hospital of Guangzhou Medical University (Approval No.: 202092). The study is reported in accordance with ARRIVE guidelines.